Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,208,300 | 1,068,900 | 1,197,979 | 1,126,107 | 1,045,700 |
| Cost of Goods | 116,400 | 134,100 | 153,516 | 128,880 | 116,300 |
| Gross Profit | 1,091,900 | 934,800 | 1,044,463 | 997,227 | 929,400 |
| Operating Expenses | 844,100 | 598,300 | 790,428 | 940,598 | 1,616,100 |
| Operating Income | 248,200 | 336,600 | 254,551 | 57,509 | -686,400 |
| Interest Expense | 37,100 | 39,900 | 45,375 | 48,576 | 47,400 |
| Other Income | -200 | 2,500 | -755 | 55 | -1,900 |
| Pre-tax Income | 210,900 | 299,200 | 208,421 | 8,988 | -735,700 |
| Income Tax | 18,100 | 6,100 | 4,981 | -242,424 | -17,200 |
| Net Income Continuous | 192,800 | 293,100 | 203,440 | 251,412 | -718,500 |
| Net Income | $192,800 | $293,100 | $203,440 | $251,412 | $-718,500 |
| EPS Basic Total Ops | 3.05 | 4.73 | 3.28 | 4.14 | -11.74 |
| EPS Basic Continuous Ops | 3.05 | 4.74 | 3.27 | 4.14 | -11.74 |
| EPS Diluted Total Ops | 2.78 | 4.43 | 3.34 | 4.08 | -11.74 |
| EPS Diluted Continuous Ops | 2.78 | 4.43 | 3.34 | 4.08 | -11.74 |
| EPS Diluted Before Non-Recurring Items | N/A | 5.46 | 5.76 | 6.99 | -9.07 |
| EBITDA(a) | $427,300 | $518,000 | $433,720 | $235,837 | $-512,400 |